In a further step, we integrate MFA data with patient-derived gene expression data from The Cancer Genome Atlas (TCGA) (http://cancergenome.nih.gov/) to predict the metabolic profiles of normal brain and IDH-mutant gliomas. Here, IDH2 is linked to central nervous system cancer.